Global Angioscope Device Market - Forecasts from 2018 to 2023

Global Angioscope Device Market - Forecasts from 2018 to 2023

Global angioscope devices market is projected to grow at a CAGR of XX% during the forecast period to reach US $XX billion by 2023 from US $XX billion in 2017. Angioscope is a flexible endoscopic devices that is used to assess and examine the interior of the blood vessel and is more accurate in identifying and treating blood vessel obstructions. Angioscope is used to assess vascular diseases, thrombus composition and staging of atherosclerosis. The advantages of the angioscope is onsite bypass process for direct visualization of valves and it also provides the insight about the treatments that should be given to patient for best outcomes. Increase in ageing population coupled with the rise in prevalence of cardiovascular disease is rapidly driving the need of angioscope devices globally. Moreover, rising prevalence of lifestyle diseases such as hypertension, diabetes and atherosclerosis are not only increasing the risk of cardiovascular diseases but also raising the demand for angioscope devices for treatment and diagnostic purpose.

Main driver of the angioscope device market is increasing investment by the companies and government funding in the research and development of the angioscope devices. Improving healthcare infrastructure in developing countries and increasing adoption of minimally invasion procedures is also the reason for growth of the market. However, high cost of the equipment coupled with unfavourable reimbursement policies in developing countries are the major factors which restrain the growth of the angioscope device market. Despite the restraint, the global angioscope device market is estimated to show a robust growth during the forecast period.

Geographically, the global angioscope device market is segmented as North America, Europe, South America, Middle East and Africa, and Asia-Pacific. North America and Europe enjoy a favourable market share owing to the rise in lifestyle disease and cardiovascular disease along with the convenient reimbursement policies in both the regions. Asia-Pacific region has substantial market growth potential owing to the rising investment in healthcare infrastructure and rising awareness about the cardiovascular diseases.

The global angiocope device market is highly competitive due to presence of huge consumer base and presence of well-established players such as Olympus. The growing need for adoption of existing technology, intense competition and further investment on technological upgrades is paving the way for mergers and acquisitions by big market players to boost their market presence. Competitive landscape details, products, strategies, and investments being done by key companies has been provided in the report.

Some of the major players discussed in this report are LeMaitre Vascular, Inc., Fibertech Co. Ltd, Olympus Corporation, B. Braun Melsungen AG, Karl Storz SE & Co. KG and VerAvanti.

Segmentation

The global angioscope device market has been segmented by component, application, end-user and geography.

By Component

Imaging Devices

Angioscopic Cathetar

Optical fibers

Lens

Others


By Application 

Diagnostic

Therapeutic


By End-user 

Hospitals

Ambulatory Centers

Research


By Geography

Introduction

North America

South America

Europe

Middle East and Africa

Asia Pacific


Key insights offered

What will be the global angioscope device market size from 2017 to 2023?

How are the major drivers and restraints affecting the global angioscope device market growth and the opportunities which exist for key vendors?

Which segment and region will drive or lead the market growth and why?

A comprehensive analysis of competitive landscape and key market participants’ behaviour

Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth.

1. Introduction
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. Research Methodology
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. Key Findings of the Study
4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Pipeline Products
5. Global Angioscope Devices Market Forecast by Component (US$ billion)
5.1. Introduction
5.2. Imaging Devices
5.3. Angioscopic Cathetar
5.4. Optical fibers
5.5. Lens
5.6. Others
6. Global Angioscope Devices Market Forecast by Application (US$ billion)
6.1. Introduction
6.2. Diagnostic 
6.3. Therapeutic 
7. Global Angioscope Devices Market Forecast by end-user (US$ billion)
7.1. Introduction
7.2. Hospitals
7.3. Ambulatory Centers
7.4. Research
8. Global Angioscope Market Forecast by Geography (US$ billion)
8.1. Introduction
8.2. North America
8.3. South America
8.4. Europe
8.5. Middle East and Africa
8.6. Asia Pacific 
9. Competitive intelligence
9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals
10. Company profiles
10.1. LeMaitre Vascular, Inc.
10.1.1. Overview
10.1.2. Financials
10.1.3. Product and Services
10.1.4. Key Developments
10.2. Fibertech Co. Ltd
10.2.1. Overview
10.2.2. Financials
10.2.3. Product and Services
10.2.4. Key Developments
10.3. Olympus Corporation
10.3.1. Overview
10.3.2. Financials
10.3.3. Product and Services
10.3.4. Key Developments
10.4. B. Braun Melsungen AG
10.4.1. Overview
10.4.2. Financials
10.4.3. Product and Services
10.4.4. Key Developments
10.5. Karl Storz SE & Co. KG
10.5.1. Overview
10.5.2. Financials
10.5.3. Product and Services
10.5.4. Key Developments
10.6. VerAvanti
10.6.1. Overview
10.6.2. Financials
10.6.3. Product and Services
10.6.4. Key Developments

LeMaitre Vascular, Inc.
Fibertech Co. Ltd
Olympus Corporation
B. Braun Melsungen AG
Karl Storz SE & Co. KG
VerAvanti
  • SKU:
  • Publishing Date: 2018-06-18
  • Product Code: 1
  • Availability: In Stock
  • $3,800.00
  • Ex Tax: $3,800.00

Available Options